U.S. FDA approves AstraZeneca’s immunotherapy for bladder cancer – Yahoo Finance
|
U.S. FDA approves AstraZeneca's immunotherapy for bladder cancer
Yahoo Finance May 1 (Reuters) – The U.S. Food and Drug Administration on Monday granted accelerated approval to AstraZeneca Plc's immuno-oncology drug to treat a type of bladder cancer in patients whose disease progressed despite chemotherapy. The drug, called … |
